Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Tornín

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Clinical Medicine|March 6, 2021
Cold Atmospheric Plasma: A New Strategy Based Primarily on Oxidative Stress for Osteosarcoma TherapyMiguel Mateu-Sanz, Juan Tornín, Maria-Pau Ginebra, et al.
Free Radical Biology & Medicine|July 17, 2022
Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancerMiguel Mateu-Sanz, María-Pau Ginebra, Juan Tornín, et al.
Biomedicines|January 21, 2023
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in CancerDzohara Murillo, Carmen Huergo, Borja Gallego, et al.
Free Radical Biology & Medicine|January 5, 2021
Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell propertiesJuan Tornín, Aranzazu Villasante, Xavi Solé-Martí, et al.
International Journal of Molecular Sciences|June 24, 2022
Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant ModelsBorja Gallego, Dzohara Murillo, Verónica Rey, et al.
Cancers|January 23, 2020
Cold Plasma-Treated Ringer's Saline: A Weapon to Target OsteosarcomaMiguel Mateu-Sanz, Juan Tornín, Bénédicte Brulin, et al.
Free Radical Biology & Medicine|October 16, 2023
Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cellsJuan Tornín, Borja Gallego, Verónica Rey, et al.
Redox Biology|March 29, 2023
Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcomaJuan Tornín, Miguel Mateu-Sanz, Verónica Rey, et al.
BMC Biology|January 9, 2026
Proteomics analysis of human mesenchymal stromal/stem cell sarcomagenesis model identifies ALDH1A3 and CD99 as potential targets in the transformation processJonathan M Gobin, Jun Gao, Veronica Rey, et al.
Scientific Reports|April 28, 2022
Proof of concept for the use of trained sniffer dogs to detect osteosarcomaAgustín Ortal, Aida Rodríguez, María Pilar Solis-Hernández, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Clinical Medicine|March 6, 2021
Cold Atmospheric Plasma: A New Strategy Based Primarily on Oxidative Stress for Osteosarcoma TherapyMiguel Mateu-Sanz, Juan Tornín, Maria-Pau Ginebra, et al.
Free Radical Biology & Medicine|July 17, 2022
Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancerMiguel Mateu-Sanz, María-Pau Ginebra, Juan Tornín, et al.
Biomedicines|January 21, 2023
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in CancerDzohara Murillo, Carmen Huergo, Borja Gallego, et al.
Free Radical Biology & Medicine|January 5, 2021
Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell propertiesJuan Tornín, Aranzazu Villasante, Xavi Solé-Martí, et al.
International Journal of Molecular Sciences|June 24, 2022
Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant ModelsBorja Gallego, Dzohara Murillo, Verónica Rey, et al.
Cancers|January 23, 2020
Cold Plasma-Treated Ringer's Saline: A Weapon to Target OsteosarcomaMiguel Mateu-Sanz, Juan Tornín, Bénédicte Brulin, et al.
Free Radical Biology & Medicine|October 16, 2023
Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cellsJuan Tornín, Borja Gallego, Verónica Rey, et al.
Redox Biology|March 29, 2023
Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcomaJuan Tornín, Miguel Mateu-Sanz, Verónica Rey, et al.
BMC Biology|January 9, 2026
Proteomics analysis of human mesenchymal stromal/stem cell sarcomagenesis model identifies ALDH1A3 and CD99 as potential targets in the transformation processJonathan M Gobin, Jun Gao, Veronica Rey, et al.
Scientific Reports|April 28, 2022
Proof of concept for the use of trained sniffer dogs to detect osteosarcomaAgustín Ortal, Aida Rodríguez, María Pilar Solis-Hernández, et al.
Pageof 2